Cargando…

Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus

BACKGROUND: We have here assessed the impact of demographic, clinical, and treatment compliance characteristics on health-related quality of life (HRQoL) of Venezuelan patients with systemic lupus erythematosus (SLE). We have used a disease-specific questionnaire, the Lupus Quality of Life (LupusQoL...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrión-Nessi, Fhabián S., Marcano-Rojas, María V., Romero Arocha, Sinibaldo R., Mendoza Millán, Daniela L., Forero-Peña, David A., Antuarez-Magallanes, Allen W., Al Snih, Soham, Rodríguez, Martín A., Fuentes-Silva, Yurilís J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725562/
https://www.ncbi.nlm.nih.gov/pubmed/34983688
http://dx.doi.org/10.1186/s41927-021-00232-0
_version_ 1784626144936460288
author Carrión-Nessi, Fhabián S.
Marcano-Rojas, María V.
Romero Arocha, Sinibaldo R.
Mendoza Millán, Daniela L.
Forero-Peña, David A.
Antuarez-Magallanes, Allen W.
Al Snih, Soham
Rodríguez, Martín A.
Fuentes-Silva, Yurilís J.
author_facet Carrión-Nessi, Fhabián S.
Marcano-Rojas, María V.
Romero Arocha, Sinibaldo R.
Mendoza Millán, Daniela L.
Forero-Peña, David A.
Antuarez-Magallanes, Allen W.
Al Snih, Soham
Rodríguez, Martín A.
Fuentes-Silva, Yurilís J.
author_sort Carrión-Nessi, Fhabián S.
collection PubMed
description BACKGROUND: We have here assessed the impact of demographic, clinical, and treatment compliance characteristics on health-related quality of life (HRQoL) of Venezuelan patients with systemic lupus erythematosus (SLE). We have used a disease-specific questionnaire, the Lupus Quality of Life (LupusQoL), validated in our patient population, to measure HRQoL. METHODS: A cross-sectional study was conducted among 100 patients with SLE from outpatient clinics. Patients completed a form with demographic, clinical, and treatment compliance data, and the LupusQoL questionnaire. HRQoL was classified as better or worse according to previously established cut-off points for this patient population. Spearman’s r test was used to determine the correlations between age, years of education, disease duration, SLEDAI, and SLICC-DI with the eight domains of the LupusQoL. Mann–Whitney U test was used to compare the HRQoL between the two groups of patients according to treatment compliance. Binomial logistic regression using the backward stepwise selection method was performed to identify the risk factors associated with each of the eight domains of the LupusQoL among patients with inactive (SLEDAI < 4) and active (SLEDAI ≥ 4) SLE. RESULTS: HRQoL of our patients was classified as better in all domains of the LupusQoL. Age correlated negatively with all domains of the LupusQoL, except with “burden to others”, and disease activity correlated negatively with all domains of the LupusQoL, except with “intimate relationships” and “burden to others” (p < 0.05). Patients who fully complied with indicated treatment had higher scores in “physical health” domain compared to patients who did not comply with at least one of the prescribed medications (p < 0.05). In patients with active SLE, a risk factor associated with worse “planning” and “intimate relationships” was advanced age, while having had SLE flare-ups in the previous six months was a risk factor associated with worse “physical health” (p < 0.05). CONCLUSION: Age and disease activity were negatively correlated with almost all domains of the LupusQoL, and treatment compliance was associated with higher score in the “physical health” domain. Disease control and treatment compliance should be the main goals for a better HRQoL in our patients with SLE.
format Online
Article
Text
id pubmed-8725562
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87255622022-01-06 Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus Carrión-Nessi, Fhabián S. Marcano-Rojas, María V. Romero Arocha, Sinibaldo R. Mendoza Millán, Daniela L. Forero-Peña, David A. Antuarez-Magallanes, Allen W. Al Snih, Soham Rodríguez, Martín A. Fuentes-Silva, Yurilís J. BMC Rheumatol Research BACKGROUND: We have here assessed the impact of demographic, clinical, and treatment compliance characteristics on health-related quality of life (HRQoL) of Venezuelan patients with systemic lupus erythematosus (SLE). We have used a disease-specific questionnaire, the Lupus Quality of Life (LupusQoL), validated in our patient population, to measure HRQoL. METHODS: A cross-sectional study was conducted among 100 patients with SLE from outpatient clinics. Patients completed a form with demographic, clinical, and treatment compliance data, and the LupusQoL questionnaire. HRQoL was classified as better or worse according to previously established cut-off points for this patient population. Spearman’s r test was used to determine the correlations between age, years of education, disease duration, SLEDAI, and SLICC-DI with the eight domains of the LupusQoL. Mann–Whitney U test was used to compare the HRQoL between the two groups of patients according to treatment compliance. Binomial logistic regression using the backward stepwise selection method was performed to identify the risk factors associated with each of the eight domains of the LupusQoL among patients with inactive (SLEDAI < 4) and active (SLEDAI ≥ 4) SLE. RESULTS: HRQoL of our patients was classified as better in all domains of the LupusQoL. Age correlated negatively with all domains of the LupusQoL, except with “burden to others”, and disease activity correlated negatively with all domains of the LupusQoL, except with “intimate relationships” and “burden to others” (p < 0.05). Patients who fully complied with indicated treatment had higher scores in “physical health” domain compared to patients who did not comply with at least one of the prescribed medications (p < 0.05). In patients with active SLE, a risk factor associated with worse “planning” and “intimate relationships” was advanced age, while having had SLE flare-ups in the previous six months was a risk factor associated with worse “physical health” (p < 0.05). CONCLUSION: Age and disease activity were negatively correlated with almost all domains of the LupusQoL, and treatment compliance was associated with higher score in the “physical health” domain. Disease control and treatment compliance should be the main goals for a better HRQoL in our patients with SLE. BioMed Central 2022-01-04 /pmc/articles/PMC8725562/ /pubmed/34983688 http://dx.doi.org/10.1186/s41927-021-00232-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Carrión-Nessi, Fhabián S.
Marcano-Rojas, María V.
Romero Arocha, Sinibaldo R.
Mendoza Millán, Daniela L.
Forero-Peña, David A.
Antuarez-Magallanes, Allen W.
Al Snih, Soham
Rodríguez, Martín A.
Fuentes-Silva, Yurilís J.
Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus
title Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus
title_full Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus
title_fullStr Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus
title_full_unstemmed Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus
title_short Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus
title_sort impact of demographic, clinical, and treatment compliance characteristics on quality of life of venezuelan patients with systemic lupus erythematosus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725562/
https://www.ncbi.nlm.nih.gov/pubmed/34983688
http://dx.doi.org/10.1186/s41927-021-00232-0
work_keys_str_mv AT carrionnessifhabians impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT marcanorojasmariav impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT romeroarochasinibaldor impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT mendozamillandanielal impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT foreropenadavida impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT antuarezmagallanesallenw impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT alsnihsoham impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT rodriguezmartina impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus
AT fuentessilvayurilisj impactofdemographicclinicalandtreatmentcompliancecharacteristicsonqualityoflifeofvenezuelanpatientswithsystemiclupuserythematosus